日付 | 受信時刻 | ニュースソース | 見出し | コード | 企業名 |
2024/03/02 | 07 : 04 | Edgar (US Regulatory) | Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 | USOTC:NWBO | Northwest Biotherapeutics Inc (QB) |
2023/12/02 | 10 : 31 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | USOTC:NWBO | Northwest Biotherapeutics Inc (QB) |
2023/12/02 | 10 : 31 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | USOTC:NWBO | Northwest Biotherapeutics Inc (QB) |
2023/11/17 | 07 : 11 | Edgar (US Regulatory) | Form 8-K - Current report | USOTC:NWBO | Northwest Biotherapeutics Inc (QB) |
2023/11/15 | 21 : 19 | InvestorsHub NewsWire | Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia | USOTC:NWBO | Northwest Biotherapeutics Inc (QB) |
2023/11/10 | 06 : 30 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | USOTC:NWBO | Northwest Biotherapeutics Inc (QB) |
2023/11/09 | 22 : 00 | InvestorsHub NewsWire | Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 | USOTC:NWBO | Northwest Biotherapeutics Inc (QB) |
2023/11/07 | 21 : 29 | InvestorsHub NewsWire | Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo | USOTC:NWBO | Northwest Biotherapeutics Inc (QB) |
2023/08/10 | 05 : 36 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | USOTC:NWBO | Northwest Biotherapeutics Inc (QB) |
2023/04/06 | 08 : 32 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | USOTC:NWBO | Northwest Biotherapeutics Inc (QB) |
2023/04/05 | 22 : 31 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | USOTC:NWBO | Northwest Biotherapeutics Inc (QB) |
2023/03/13 | 20 : 35 | InvestorsHub NewsWire | Nightfood, Inc. (OTCQB: NGTF) now in Sonesta International Hotels Multiple Brands | USOTC:NWBO | Northwest Biotherapeutics Inc (QB) |
2023/03/01 | 06 : 31 | Edgar (US Regulatory) | Annual Report (10-k) | USOTC:NWBO | Northwest Biotherapeutics Inc (QB) |
2023/02/08 | 07 : 55 | Edgar (US Regulatory) | Annual Statement of Changes in Beneficial Ownership (5) | USOTC:NWBO | Northwest Biotherapeutics Inc (QB) |
2023/01/14 | 06 : 34 | Edgar (US Regulatory) | Current Report Filing (8-k) | USOTC:NWBO | Northwest Biotherapeutics Inc (QB) |
2023/01/07 | 06 : 42 | Edgar (US Regulatory) | Current Report Filing (8-k) | USOTC:NWBO | Northwest Biotherapeutics Inc (QB) |
2022/12/24 | 07 : 24 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (defa14a) | USOTC:NWBO | Northwest Biotherapeutics Inc (QB) |
2022/12/17 | 03 : 40 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (defa14a) | USOTC:NWBO | Northwest Biotherapeutics Inc (QB) |
2022/12/05 | 21 : 01 | Edgar (US Regulatory) | Proxy Statement (definitive) (def 14a) | USOTC:NWBO | Northwest Biotherapeutics Inc (QB) |
2022/12/02 | 00 : 29 | TipRanks | Northwest Bio Accuses Market Makers of Share Price Manipulation | USOTC:NWBO | Northwest Biotherapeutics Inc (QB) |
2022/11/26 | 07 : 30 | Edgar (US Regulatory) | Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) | USOTC:NWBO | Northwest Biotherapeutics Inc (QB) |
2022/11/10 | 06 : 31 | Edgar (US Regulatory) | Quarterly Report (10-q) | USOTC:NWBO | Northwest Biotherapeutics Inc (QB) |
2022/09/27 | 22 : 33 | InvestorsHub NewsWire | Acquisition Completed: Endexx (EDXC)'s HYLA Secures 200k+ Unit Order; 4,500 Puffs per Unit | USOTC:NWBO | Northwest Biotherapeutics Inc (QB) |
2022/07/01 | 06 : 09 | Edgar (US Regulatory) | Amended Annual Report (10-k/a) | USOTC:NWBO | Northwest Biotherapeutics Inc (QB) |
2022/05/10 | 19 : 02 | Edgar (US Regulatory) | Quarterly Report (10-q) | USOTC:NWBO | Northwest Biotherapeutics Inc (QB) |
2022/05/03 | 06 : 05 | Edgar (US Regulatory) | Amended Annual Report (10-k/a) | USOTC:NWBO | Northwest Biotherapeutics Inc (QB) |
2022/04/12 | 21 : 30 | InvestorsHub NewsWire | TNS Issues New Reports on Stocks with Potential Near Term Catalysts and a Feature Green Energy NASDAQ Report | USOTC:NWBO | Northwest Biotherapeutics Inc (QB) |
2022/03/17 | 21 : 00 | InvestorsHub NewsWire | TNS Feature Report and Next Gen Tech and Biotech That Could Change Our Lives | USOTC:NWBO | Northwest Biotherapeutics Inc (QB) |
2022/03/04 | 23 : 11 | InvestorsHub NewsWire | Seeking Alpha - ALYI sees substantial interest for new EV taxi program | USOTC:NWBO | Northwest Biotherapeutics Inc (QB) |
2022/03/02 | 02 : 49 | Edgar (US Regulatory) | Annual Report (10-k) | USOTC:NWBO | Northwest Biotherapeutics Inc (QB) |